Taro Pharmaceutical Industries Ltd (NYSE:TARO)

153.13
Delayed Data
As of Feb 26
 -1.78 / -1.15%
Today’s Change
102.72
Today|||52-Week Range
173.00
+3.33%
Year-to-Date
No recent news for Taro Pharmaceutical Industries Ltd.

Today’s Trading

Previous close154.91
Today’s open154.18
Day’s range152.96 - 154.68
Volume50,560
Average volume (3 months)63,925
Market cap$6.6B
Dividend yield--
Data as of 02/26/2015

Growth & Valuation

Earnings growth (last year)+36.58%
Earnings growth (this year)+30.26%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+13.16%
P/E ratio--
Price/Sales6.47
Price/Book6.53

Competitors

 Today’s
change
Today’s
% change
OPKOPKO Health Inc-0.19-1.26%
PBYIPuma Biotechnology I...+1.51+0.74%
UTHRUnited Therapeutics ...-2.34-1.48%
IDXXIDEXX Laboratories I...+0.94+0.60%
Data as of 02/26/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$759.3M
Annual profit (last year)$360.4M
Net profit margin47.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Kal Sundaram
Chief Financial &
Accounting Officer, Group VP
Michael Kalb
Corporate headquarters
Haifa Bay, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account